Chronic treatment with palmitate induces insulin hypersecretion and later impairment of human islet function and has frequently been used for obese and diabetes modeling in vitro (Cen et al., 2016; Kristinsson et al., 2017; Groebe et al., 2018). The gene discussed is INS; the disease is diabetes mellitus.